戻る Agenda
Session 4C: Identification of Medicinal Products (IDMP)- Updates and Implementation Approaches
Session Chair(s)
Maggie Graham
Senior Policy Analyst, Natural and Non-Prescription Health Products Directorate
Health Canada, Canada
The ISO IDMP standard, and the European implementation of it, present a number of challenges in terms of the data that must be collected, managed, and submitted to the agencies. Explore how companies can – and should already be starting to – approach IDMP implmentation. Speakers will address how to design new processes for handling IDMP requirements and how to react to evolving requirements.
Speaker(s)
Session Co-Chair
Donald Palmer, MA
United States
Consultant
IDMP: Incrememental Data, More Processes
Joel Finkle
Retired, United States
Industry Expert
IDMP Overview and a Regulators Perspective
Vikesh Srivastava
Health Canada, Canada
Associate Director, Business Informatics Division, HPFB
Industry Perception and Action on IDMP Standards: US and EU
Brooke Casselberry, MS, RAC
Epista Life Sciences, United States
Vice President, Advisory and Delivery